| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/24/2013 | US20130022555 Methods and materials for providing teeth with a white appearance |
| 01/24/2013 | US20130022546 Peptides that Specifically Target Amyloid Deposits |
| 01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | CA2841710A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | CA2837981A1 Rapid and accurate analysis of protein sialylation |
| 01/23/2013 | CN102887943A B cell epitope peptide segment of amino-terminal pro-brain natriuretic peptide and applications thereof |
| 01/23/2013 | CN102634530B Gene of high expression lysine |
| 01/23/2013 | CN102002105B Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 01/23/2013 | CN101967192B Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 01/23/2013 | CN101863983B Double-fluorescence co-location system based on green fluorescent protein and red fluorescent protein |
| 01/22/2013 | US8357655 Wound healing peptides and methods of use thereof |
| 01/22/2013 | CA2494192C Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 01/22/2013 | CA2489515C Methods and compositions for modulating and detecting wisp activity |
| 01/22/2013 | CA2375619C Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 01/22/2013 | CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use |
| 01/17/2013 | WO2013010028A2 COMPOSITIONS AND METHODS FOR IMPROVED CaMKII INHIBITORS AND USES THEREOF |
| 01/17/2013 | WO2013009841A1 Subsets of antigen-presenting cells (apc's) in the human vagina and their distinct functions |
| 01/17/2013 | WO2013006978A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | WO2012158639A3 Recombinant fusion proteins and methods for use thereof for treatment or prevention of papillomavirus infection |
| 01/17/2013 | WO2012158555A3 Novel fusion partners for the purpose of crystallizing g-protein coupled receptors |
| 01/17/2013 | WO2012157945A3 Method for expressing a target protein at the surface of a vacuole, and drug delivery carrier |
| 01/17/2013 | WO2012150973A9 Compositions for regulating iron homeostasis and methods of using same |
| 01/17/2013 | WO2012144778A3 Surface-active collagen barrier membrane to which a peptide is bound |
| 01/17/2013 | WO2012087966A3 Targeted perhydrolases |
| 01/17/2013 | WO2011152694A8 Fusion protein having factor vii activity |
| 01/17/2013 | US20130018172 Metal Abstraction Peptide and Uses Thereof |
| 01/17/2013 | US20130018000 Recombinant filaggrin polypeptides for cell importation |
| 01/17/2013 | US20130017997 Factor VIII Compositions and Methods of Making and Using Same |
| 01/17/2013 | US20130017554 Sumo-specific affinity tag |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017214 Bacteremia-associated antigen from staphylococcus aureus |
| 01/17/2013 | CA2878701A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | CA2841066A1 Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
| 01/17/2013 | CA2840951A1 Method for purifying fc-fusion protein |
| 01/16/2013 | EP2546342A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 01/16/2013 | EP2546268A1 Internalising immunoglobulin |
| 01/16/2013 | EP2545174A2 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 01/16/2013 | EP2545080A2 Npp1 fusion proteins |
| 01/16/2013 | CN1954073B Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 01/16/2013 | CN1495197B G-CSF analogs composition and its preparation method |
| 01/16/2013 | CN102884194A Methods and compositions containing Fc fusiong proteins for enhancing immune responses |
| 01/16/2013 | CN102884086A Stable, functional chimeric cellobiohydrolase class I enzymes |
| 01/16/2013 | CN102875685A Chimeric antigen receptor hFVIIL-CD8-OX40-CD3zeta and application thereof |
| 01/16/2013 | CN102875684A FGFR single-stranded antibody fusion protein and application thereof in preparing targeting tumor cells medicines |
| 01/16/2013 | CN102875683A Fc fusion protein of long-acting recombinant human growth hormone |
| 01/16/2013 | CN102875653A Alpha-conotoxin peptide, and medical composition, preparation method and purpose thereof |
| 01/16/2013 | CN101948543B Fusion protein and coding gene and application thereof |
| 01/16/2013 | CN101294164B Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody |
| 01/15/2013 | US8354510 Mutant protein |
| 01/15/2013 | US8354250 Neurotransmitter sensors and methods of using the same |
| 01/15/2013 | CA2475929C Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/10/2013 | WO2013004983A1 Novel compounds and their effects on feeding behaviour |
| 01/10/2013 | WO2013004587A1 Method for separation of monomeric polypeptides from aggregated polypeptides |
| 01/10/2013 | WO2013003987A1 Tumor-targeted tumor necrosis factor-related apoptosis ligand variant and use thereof |
| 01/10/2013 | WO2012159006A8 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
| 01/10/2013 | US20130014288 Novel reporter-tagged recombinant membrane proteins with transmembrane linkers |
| 01/10/2013 | US20130012457 Beta sheet tapes ribbons in tissue engineering |
| 01/10/2013 | US20130012455 Use of ARC for inhibiting cell death during liver failure |
| 01/10/2013 | US20130012453 Acceleration Of Wound Healing By A Tissue Inhibitor Of Metalloproteinases (TIMP) Linked To Glycosylphosphatidylinositol (GPI)-Anchors |
| 01/10/2013 | US20130012435 Multivalent fibronectin based scaffold domain proteins |
| 01/10/2013 | US20130011436 Methods and Compositions Containing Fc Fusion Proteins for Enhancing Immune Responses |
| 01/10/2013 | US20130011432 Disrupted adenovirus-based vaccine against drugs of abuse |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011426 Recombinant Vaccines and Use Thereof |
| 01/10/2013 | US20130011424 Polyepitope constructs and methods for their preparation and use |
| 01/10/2013 | US20130011419 Cross-linkers and their uses |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011403 Klebsiella antigens |
| 01/10/2013 | US20130011399 WAP Domain Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011394 Complexes comprising mhc class i fusion polypeptides and antigen-specific antibodies and methods of use |
| 01/10/2013 | US20130011338 Cupredoxin derived transport agents and methods of use thereof |
| 01/10/2013 | CA2840221A1 P97-antibody conjugates and methods of use |
| 01/10/2013 | CA2835607A1 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/09/2013 | EP2542680A1 Uv associated mtdna fusion transcripts and methods and uses thereof |
| 01/09/2013 | EP2542590A2 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 01/09/2013 | CN102869778A High level expression of recombinant toxin proteins |
| 01/09/2013 | CN102869676A Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability |
| 01/09/2013 | CN102863539A Fusion tandem antibacterial peptide and preparation method thereof |
| 01/09/2013 | CN102863538A Fused polypeptide mutant containing protein transduction domain and preparation method thereof |
| 01/09/2013 | CN102863537A Tumor targeting tumor necrosis factor related apoptosis ligand variant and application thereof |
| 01/09/2013 | CN102863536A Fusion protein GPR85-Gilalpha, its coding gene and application |
| 01/09/2013 | CN102863535A Fusion protein GPR45-Gilalpha, its coding gene and application |
| 01/09/2013 | CN102863534A Fusion protein GPR174-Gilalpha, its coding gene and application |
| 01/09/2013 | CN102863520A Recombinant protein comprising starch binding domain and use thereof |
| 01/09/2013 | CN102174111B Human interleukin-2 (IL-2)/Fc fusion protein and uses |
| 01/09/2013 | CN102166348B Application of inhibin recombinant fusion protein to preparing medicines for promoting oestrus and hybridization of sows |
| 01/09/2013 | CN102161998B Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof |
| 01/09/2013 | CN102041263B Chicken alpha interferon/interleukin 2 chimeric gene |
| 01/08/2013 | US8350008 WISP polypeptides and nucleic acids encoding same |
| 01/08/2013 | US8349798 Caveolin peptides and their use as therapeutics |
| 01/08/2013 | US8349331 Anti-interferon-α antibodies |
| 01/08/2013 | CA2492930C Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 01/08/2013 | CA2317727C Multipurpose antibody derivatives |
| 01/03/2013 | WO2013003649A2 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013003641A2 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013003557A1 Photoactivatable receptors and their uses |
| 01/03/2013 | WO2013003555A1 Using sortases to install click chemistry handles for protein ligation |
| 01/03/2013 | WO2013003219A1 Pentose fermentation by a recombinant microorganism |
| 01/03/2013 | WO2013000234A1 A novel recomnimant bifunctional fusion protein and its preparation and use |